Mitchell C. Posner to Molecular Targeted Therapy
This is a "connection" page, showing publications Mitchell C. Posner has written about Molecular Targeted Therapy.
Connection Strength
0.039
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.039